Observations from a peculiar case of volatile substance dependence–A case report

References

• American Psychiatric Association. 2013. DSM-5 diagnostic classification. In: Diagnostic and statistical manual of mental disorders. Washington, DC: American Psychiatric Association. doi:10.1176/appi.books.9780890425596.x00diagnosticclassification.
   Google Scholar
• Beauvais F, Oetting ER. Toward a clear definition of inhalant abuse. Int J Addict. 1987; 22(8):779–84. doi:10.3109/10826088709027457.
   PubMed Web of Science ®Google Scholar
• Waraich BK, Chavan BS, Raj L. Inhalant abuse: A growing public health concern in India. Addiction. 2003; 98(8):1169. doi:10.1046/j.1360-0443.2003.00469.x.
   PubMed Web of Science ®Google Scholar
• Muilenburg JL, Johnson WD. Inhalant use and risky behavior correlates in a sample of rural middle school students. Subst Abus. 2006; 27(4):21–5. doi:10.1300/J465v27n04_03.
   PubMedGoogle Scholar
• Kumar S, Grover S, Kulhara P, Mattoo SK, Basu D, Biswas P, Shah R. Inhalant abuse: A clinic-based study. Indian J Psychiatry. 2008; 50(2):117–20. doi:10.4103/0019-5545.42399.
   PubMedGoogle Scholar
• De La Rosa M, et al. Epidemiology of inhalant abuse: An international perspective. Proceedings of a meeting. NIDA research monograph; July 21–22, 1993; 1995, p. 1–306.
   Google Scholar
• Lorenc JD. Inhalant abuse in the pediatric population: A persistent challenge. Curr Opin Pediatr. 2003; 15(2):204–9. doi:10.1097/00008480-200304000-00012.
   PubMed Web of Science ®Google Scholar
• Williams JF, Storck M, American Academy of Pediatrics Committee on Native American Child Health. Inhalant abuse. Am Acad Pediatr. 2007; 119(5):1009–1017. doi:10.1542/peds.2007-0470.
   PubMed Web of Science ®Google Scholar
• Meadows R, Verghese A. Medical complications of glue sniffing. South Med J. 1996; 89(5):455–62. doi:10.1097/00007611-199605000-00001.
   PubMed Web of Science ®Google Scholar
• Maruff P, Burns CB, Tyler P, Currie BJ, Currie J. Neurological and cognitive abnormalities associated with chronic petrol sniffing. Brain. 1998; 121(10):1903–17. doi:10.1093/brain/121.10.1903.
   PubMed Web of Science ®Google Scholar
• Rosenberg NL, Grigsby J, Dreisbach J, Busenbark D, Grigsby P. Neuropsychologic impairment and MRI abnormalities associated with chronic solvent abuse. J Toxicol Clin Toxicol. 2002; 40(1):21–34. doi:10.1081/CLT-120002883.
   PubMed Web of Science ®Google Scholar
• Brouette T, Anton R. Clinical review of inhalants. Am J Addict. 2001; 10(1):79–94. doi:10.1080/105504901750160529.
   PubMed Web of Science ®Google Scholar
• Teck-Hong O. Inhalant abuse in Singapore. Int J Addict. 1986; 21(8):955–60. doi:10.3109/10826088609027408.
   PubMed Web of Science ®Google Scholar
• Medina-Mora ME, Berenzon S. Epidemiology of inhalant abuse in Mexico. NIDA Res Monogr Ser. 1995; 148:136–74.
   PubMedGoogle Scholar
• Ramon MF, Ballesteros S, Martinez‐Arrieta R, Jorrecilla JM, Cabrera J. Volatile substance and other drug abuse inhalation in Spain. J Toxicol - Clin Toxicol. 2003; 41(7):931–6.
   PubMed Web of Science ®Google Scholar
• Beasley M, Frampton L, Fountain J. Inhalant abuse in New Zealand. N Z Med J. 2006; 119(1233):U1952.
   PubMedGoogle Scholar
• Chakroun R, Faidi F, Hedhili A, Charbaji K, Nouaigui H, Laiba MB. Inhalant abuse detection and evaluation in young Tunisians. J Forensic Sci. 2008; 53(1):232–7. doi:10.1111/j.1556-4029.2007.00623.x.
   PubMed Web of Science ®Google Scholar
• Beauvais F, Oetting ER. Inhalant abuse by young children. NIDA Res Monogr Ser. 1988; 85:30–3.
   PubMedGoogle Scholar
• Smart RG. Inhalant use and abuse in Canada. NIDA Res Monogr Ser. 1988; 85:121–39.
   PubMedGoogle Scholar
• Ambekar A, Rao M, Chadda K. 2019. Ministry of social justice and empowerment magnitude of substance use. Available from: https://www.muktangan.org/pdf/Magnitude_Substance_Use_India_REPORT.pdf.
   Google Scholar
• Shah R, Vankar GK, Upadhyaya HP. Phenomenology of gasoline intoxication and withdrawal symptoms among adolescents in India: A case series. Am J Addict. 1999; 8(3):254–7. doi:10.1080/105504999305866.
   PubMed Web of Science ®Google Scholar
• Narayanaswamy JC, Viswanath B, Ravi M, Muralidharan K. Inhalant dependence: Data from a tertiary care center in South India. Indian J Psychol Med. 2012; 34(3):232–6. doi:10.4103/0253-7176.106017.
   PubMedGoogle Scholar
• Gupta S, Nebhinani N, Basu D, Mattoo SK. Profile of inhalant users seeking treatment at a de-addiction centre in north India. Indian J Med Res. 2014; 139(5):708–13.
   PubMed Web of Science ®Google Scholar
• Joshi M, Vankar G. Gasoline abuse in a 10-year-old child with mental retardation: A case report. Subst Abuse. 2015; 9:5–8. doi:10.4137/SART.S20148.
   PubMed Web of Science ®Google Scholar
• Ningombam S, Hutin Y, Murhekar MV. Prevalence and pattern of substance use among the higher secondary school students of Imphal, Manipur, India. Natl Med J India. 2011; 24:11–5.
   PubMed Web of Science ®Google Scholar
• Benegal V, Bhushan K, Seshadri S, Karott M. 1998. Drug abuse among street children in Bangalore, 1–19.
   Google Scholar
• Pagare D, Meena GS, Singh MM, Sahu R. Risk factors of substance use among street children from Delhi. Indian Pediatr. 2004; 41(3):221–5.
   PubMedGoogle Scholar
• Dhawan A, Pattanayak RD, Chopra A. 2013. Assessment of pattern, profile and correlates of substance use among children in India, 1–118.
   Google Scholar
• Rinsky RA. Benzene and leukemia: An epidemiologic risk assessment. Environ Health Perspect. 1989; 82:189–91. doi:10.1289/ehp.8982189.
   PubMed Web of Science ®Google Scholar
• Sakai JT, Hall SK, Mikulich-Gilbertson SK, Crowley TJ. Inhalant use, abuse, and dependence among adolescent patients: Commonly comorbid problems. J Am Acad Child Adolesc Psychiatry. 2004; 43(9):1080–8. doi:10.1097/01.chi.0000132813.44664.64.
   PubMed Web of Science ®Google Scholar
• Zubaran C, Foresti K, Thorell MR, Franceschini P, Homero W. Depressive symptoms in crack and inhalant users in Southern Brazil. J Ethn Subst Abuse. 2010;9(3):221–236. doi:10.1080/15332640.2010.501626.
   PubMedGoogle Scholar
• Wu LT, Howard MO. Psychiatric disorders in inhalant users: Results from The National Epidemiologic Survey on alcohol and related conditions. Drug Alcohol Depend. 2007; 88(2–3):146–155. doi:10.1016/j.drugalcdep.2006.10.012.
   PubMed Web of Science ®Google Scholar
• Virmani A, Binienda ZK, Ali SF, Gaetani F. Metabolic syndrome in drug abuse. Ann N Y Acad Sci. 2007; 1122:50–68. doi:10.1196/annals.1403.004.
   PubMed Web of Science ®Google Scholar
• Virmani A, Gaetani F, Binienda Z. Effects of metabolic modifiers such as carnitines, coenzyme Q10, and PUFAs against different forms of neurotoxic insults: Metabolic inhibitors, MPTP, and methamphetamine. Ann N Y Acad Sci. 2005; 1053(1):183–91. doi:10.1196/annals.1344.016.
   PubMedGoogle Scholar
• Quraishi R, Pattanayak RD, Jain R, Dhawan A. A descriptive study of clinical, hematological, and biochemical parameters of inhalant users seeking treatment at a tertiary care center in India. Indian J Psychol Med. 2013; 35(2):174–9. doi:10.4103/0253-7176.116249.
   PubMedGoogle Scholar
• Beard JL, Hendricks MK, Perez EM, Murray-Kolb LE, Berg A, Vernon-Feagans L, Irlam J, Isaacs W, Sive A, Tomlinson M, et al. Maternal iron deficiency anemia affects postpartum emotions and cognition. J Nutr. 2005; 135(2):267–72. doi:10.1093/jn/135.2.267.
   PubMed Web of Science ®Google Scholar
• Stewart R, Hirani V. Relationship between depressive symptoms, anemia, and iron status in older residents from a national survey population. Psychosomatic Med. 2012; 74(2):208–13. Available from: https://journals.lww.com/psychosomaticmedicine/Fulltext/2012/02000/Relationship_Between_Depressive_Symptoms,_Anemia,.14.aspx.
   PubMed Web of Science ®Google Scholar
• Noorazar S. g, Ranjbar F, Nemati N, Yasamineh N, Kalejahi P. Relationship between severity of depression symptoms and iron deficiency anemia in women with major depressive disorder. J Anal Res Clin Med. 2015; 3(4):219–24. doi:10.15171/jarcm.2015.034.
   Google Scholar